GGrantIndex
← Leaderboards

Hariharan Easwaran

Johns Hopkins University

$3,732,530
Attributed
$8,856,600
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY201424
$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$8,856,600 · 6

By mechanism

R01$7,882,457 · 4
R21$728,517 · 1
U01$245,626 · 1

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Epigenetic Process

Research focus

Epigenetic ProcessMutationTumorPathway InteractionsCancer InitiationColonTumorigenesisOrganoidsGene ExpressionDna MethylationMethylationMalignant NeoplasmsClustered Regularly Interspaced Short Palindromic RepeatsIn VivoGenesBraf GeneTumor ProgressionAgingColorectal CancerAffectCpg IslandsPromoterStem CellsGene Silencing

Grant awards (25)

Organoid modeling to determine and reverse age-related epigenetic changes contributing to risk of colorectal cancer$49,264
R01 · FY2024 · CA
DNA Methyltransferase Gene Expression in Colon Cancer$541,697
R01 · FY2023 · ES
Organoid modeling to determine and reverse age-related epigenetic changes contributing to risk of colorectal cancer$407,205
R01 · FY2023 · CA
DNA Methyltransferase Gene Expression in Colon Cancer$541,697
R01 · FY2022 · ES
Organoid modeling to determine and reverse age-related epigenetic changes contributing to risk of colorectal cancer$407,205
R01 · FY2022 · CA
(PQ4) - Tools for simultaneous disruption of multiple epigenetically silenced genes for studying their roles in tumorigenesis using ex vivo human and mouse colon organoid and in vivo mouse models$367,087
R01 · FY2022 · CA · contact PI
DNA Methyltransferase Gene Expression in Colon Cancer$541,697
R01 · FY2021 · ES
(PQ4) - Tools for simultaneous disruption of multiple epigenetically silenced genes for studying their roles in tumorigenesis using ex vivo human and mouse colon organoid and in vivo mouse models$374,578
R01 · FY2021 · CA · contact PI
Organoid modeling to determine and reverse age-related epigenetic changes contributing to risk of colorectal cancer$240,845
R01 · FY2021 · CA
DNA Methyltransferase Gene Expression in Colon Cancer$541,697
R01 · FY2020 · ES
(PQ4) - Tools for simultaneous disruption of multiple epigenetically silenced genes for studying their roles in tumorigenesis using ex vivo human and mouse colon organoid and in vivo mouse models$374,578
R01 · FY2020 · CA · contact PI
Organoid modeling to determine and reverse age-related epigenetic changes contributing to risk of colorectal cancer$374,578
R01 · FY2020 · CA
Characterizing age-associated epigenetic alterations and their roles in tumor development$122,813
U01 · FY2020 · AG · contact PI
DNA Methyltransferase Gene Expression in Colon Cancer$577,748
R01 · FY2019 · ES
Organoid modeling to determine and reverse age-related epigenetic changes contributing to risk of colorectal cancer$374,578
R01 · FY2019 · CA
(PQ4) - Tools for simultaneous disruption of multiple epigenetically silenced genes for studying their roles in tumorigenesis using ex vivo human and mouse colon organoid and in vivo mouse models$363,340
R01 · FY2019 · CA · contact PI
High-efficiency microfluidic-assisted single-cell DNA methylome sequencing$319,767
R21 · FY2019 · CA · contact PI
Characterizing age-associated epigenetic alterations and their roles in tumor development$122,813
U01 · FY2019 · AG · contact PI
(PQ4) - Tools for simultaneous disruption of multiple epigenetically silenced genes for studying their roles in tumorigenesis using ex vivo human and mouse colon organoid and in vivo mouse models$374,578
R01 · FY2018 · CA · contact PI
High-efficiency microfluidic-assisted single-cell DNA methylome sequencing$245,250
R21 · FY2018 · CA · contact PI
High-efficiency microfluidic-assisted single-cell DNA methylome sequencing$163,500
R21 · FY2017 · CA · contact PI
(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer$9,422
R01 · FY2017 · CA
(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer$470,355
R01 · FY2016 · CA
(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer$490,967
R01 · FY2015 · CA
(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer$459,341
R01 · FY2014 · CA